{"pmid":32344275,"pmcid":"PMC7177090","title":"Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).","text":["Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).","Med Hypotheses","Altschuler, Eric L","Kast, Richard E","32344275"],"journal":"Med Hypotheses","authors":["Altschuler, Eric L","Kast, Richard E"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344275","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109774","e_drugs":["Colchicine","Dapsone","Olanzapine"],"topics":["Treatment"],"weight":1,"_version_":1666138495041667073,"score":9.490897,"similar":[{"pmid":32339778,"pmcid":"PMC7175857","title":"Dapsone and doxycycline could be potential treatment modalities for COVID-19.","text":["Dapsone and doxycycline could be potential treatment modalities for COVID-19.","Med Hypotheses","Farouk, Ahmed","Salman, Samar","32339778"],"journal":"Med Hypotheses","authors":["Farouk, Ahmed","Salman, Samar"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339778","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109768","e_drugs":["Dapsone","Doxycycline"],"topics":["Treatment"],"weight":1,"_version_":1666138494174494722,"score":49.330837},{"pmid":32442317,"title":"The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).","text":["The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).","COVID-19, the disease resulting from infection by a novel coronavirus: SARS-Cov2 that has rapidly spread since November 2019 leading to a global pandemic. SARS-Cov2 has infected over 4 million people and caused over 290,000 deaths worldwide. Although most cases are mild, a subset of patients develop a severe and atypical presentation of Acute Respiratory Distress Syndrome (ARDS) that is characterised by a cytokine release storm (CRS). Paradoxically, treatment with anti-inflammatory agents and immune regulators has been associated with worsening of ARDS. We hypothesize that the intrinsic circadian clock of the lung and the immune system may regulate individual components of CRS and thus chronotherapy may be used to effectively manage ARDS in COVID-19 patients.","Br J Pharmacol","Tamimi, Faleh","Abusamak, Mohammad","Akkanti, Bindu","Chen, Zheng","Yoo, Seung-Hee","Karmouty-Quintana, Harry","32442317"],"abstract":["COVID-19, the disease resulting from infection by a novel coronavirus: SARS-Cov2 that has rapidly spread since November 2019 leading to a global pandemic. SARS-Cov2 has infected over 4 million people and caused over 290,000 deaths worldwide. Although most cases are mild, a subset of patients develop a severe and atypical presentation of Acute Respiratory Distress Syndrome (ARDS) that is characterised by a cytokine release storm (CRS). Paradoxically, treatment with anti-inflammatory agents and immune regulators has been associated with worsening of ARDS. We hypothesize that the intrinsic circadian clock of the lung and the immune system may regulate individual components of CRS and thus chronotherapy may be used to effectively manage ARDS in COVID-19 patients."],"journal":"Br J Pharmacol","authors":["Tamimi, Faleh","Abusamak, Mohammad","Akkanti, Bindu","Chen, Zheng","Yoo, Seung-Hee","Karmouty-Quintana, Harry"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442317","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bph.15140","topics":["Treatment","Mechanism"],"weight":1,"_version_":1667535119453257728,"score":48.157986},{"pmid":32424591,"title":"COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?","text":["COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?","Cell Stress Chaperones","De Maio, Antonio","Hightower, Lawrence E","32424591"],"journal":"Cell Stress Chaperones","authors":["De Maio, Antonio","Hightower, Lawrence E"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32424591","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s12192-020-01121-0","topics":["Treatment"],"weight":1,"_version_":1667252837699026944,"score":48.053776},{"pmid":32281766,"title":"Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?","text":["Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?","J Trauma Acute Care Surg","Moore, Hunter B","Barrett, Christopher D","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Talmor, Daniel S","Moore, Frederick A","Yaffe, Michael B","32281766"],"journal":"J Trauma Acute Care Surg","authors":["Moore, Hunter B","Barrett, Christopher D","Moore, Ernest E","McIntyre, Robert C","Moore, Peter K","Talmor, Daniel S","Moore, Frederick A","Yaffe, Michael B"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281766","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1097/TA.0000000000002694","topics":["Treatment"],"weight":1,"_version_":1666138491528937472,"score":47.19134},{"pmid":32335749,"title":"How Could This Happen? : Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS).","text":["How Could This Happen? : Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS).","In this rapid commentary, a mini-review is given of the present state-of-knowledge regarding the etiology and epidemiology of the new coronavirus 2019-nCoV and the risks for developing Acute respiratory distress syndrome (ARDS). The available knowledge on the viral genomics, molecular biology and pathogenicity of viruses of the Coronaviridae family and other Nidovirales, forms a helpful template for understanding the present pandemic outbreak. However, important questions remain unanswered about the underlying mechanism causing the very high case fatality ratios (CFR) and mechanisms regarding severe reactions like ARDS, fatal cardiac and renal failures, associated with a number of important comorbidity factors. Immunological reactions to lung alveoles in particular (involving lung macrophages and alveolar epithelial cell damage) in late phase ARDS in SARS-like CoV diseases, so far may not have received enough attention. Finally a shortlist of questions for high priority further research is suggested.","Acta Biotheor","Allaerts, Wilfried","32335749"],"abstract":["In this rapid commentary, a mini-review is given of the present state-of-knowledge regarding the etiology and epidemiology of the new coronavirus 2019-nCoV and the risks for developing Acute respiratory distress syndrome (ARDS). The available knowledge on the viral genomics, molecular biology and pathogenicity of viruses of the Coronaviridae family and other Nidovirales, forms a helpful template for understanding the present pandemic outbreak. However, important questions remain unanswered about the underlying mechanism causing the very high case fatality ratios (CFR) and mechanisms regarding severe reactions like ARDS, fatal cardiac and renal failures, associated with a number of important comorbidity factors. Immunological reactions to lung alveoles in particular (involving lung macrophages and alveolar epithelial cell damage) in late phase ARDS in SARS-like CoV diseases, so far may not have received enough attention. Finally a shortlist of questions for high priority further research is suggested."],"journal":"Acta Biotheor","authors":["Allaerts, Wilfried"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335749","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s10441-020-09382-z","keywords":["acute respiratory distress syndrome","angiotensin converting enzyme 2","covid-19 (2019-ncov)","lung immunopathology","mers","sars"],"topics":["Mechanism"],"weight":1,"_version_":1666138494116823040,"score":45.047855}]}